<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The total lipids of the liver were significantly reduced in the case of TM oil and PO supplementation (
 <italic class="italic">p</italic> = 0.013). In addition, significant changes were observed in most SFAs, such as C12:0 (
 <italic class="italic">p</italic> = 0.001), C14:0 (
 <italic class="italic">p</italic> = 0.016), C15:0 (
 <italic class="italic">p</italic> &lt; 0.001), C16:0 (
 <italic class="italic">p</italic> &lt; 0.001), C17:0 (
 <italic class="italic">p</italic> &lt; 0.001), C18:0 (
 <italic class="italic">p</italic> &lt; 0.001), C20:0 (
 <italic class="italic">p</italic> = 0.003), C21:0 (
 <italic class="italic">p</italic> &lt; 0.001), C22:0 (
 <italic class="italic">p</italic> &lt; 0.001) and C24:0 (
 <italic class="italic">p</italic> &lt; 0.001); TM oil showed the lowest values for C:14 and C:16. Furthermore, significant differences were observed in most MUFAs; TM oil showed the highest values for C15:1 (
 <italic class="italic">p</italic> = 0.013), C17:1 (
 <italic class="italic">p</italic> &lt; 0.001), C20:1 
 <italic class="italic">trans</italic> (
 <italic class="italic">p</italic> &lt; 0.001) and C24:1 (
 <italic class="italic">p</italic> &lt; 0.001). PUFAs were also affected by the dietary treatments, and TM oil showed the highest values for C18:2 c9c12 (
 <italic class="italic">p</italic> &lt; 0.001), C18:3 c9c12c15 (
 <italic class="italic">p</italic> &lt; 0.001), C20:3 n-6 (
 <italic class="italic">p</italic> &lt; 0.001), C20:4 n-6 (
 <italic class="italic">p</italic> &lt; 0.001), C20:5 n-3 (
 <italic class="italic">p</italic> &lt; 0.001) and C22:5 n-3 (
 <italic class="italic">p</italic> &lt; 0.001).
</p>
